BEVERLY A. HUSS - 17 Mar 2022 Form 4 Insider Report for IRIDEX CORP (IRIX)

Role
Director
Signature
/s/ Nilo De Castro, Attorney-in-Fact for Beverly Huss
Issuer symbol
IRIX
Transactions as of
17 Mar 2022
Transactions value $
$0
Form type
4
Filing time
21 Mar 2022, 17:46:03 UTC
Previous filing
02 Dec 2021
Next filing
16 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRIX Common Stock (right to buy) Award $0 +15,000 $0.000000 15,000 17 Mar 2022 Common Stock 15,000 $4.60 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option granted pursuant to IRIDEX Corporation's 2008 Amended and Restated Equity Incentive Plan and is exempt pursuant to Rule16b-3.
F2 The shares are subject to vesting according to the following schedule: 1/48th of the total number of shares vest on April 17, 2022 and each month thereafter.